• FDA Publishes New Guidance on Letters from Manufacturers to Health Care Providers
  • February 7, 2014 | Authors: Igor Gorlach; Paul T. Kim
  • Law Firm: Foley Hoag LLP - Washington Office
  • The Food and Drug Administration (FDA) issued a new guidance document on Dear Health Care Provider (DHCP) letters, titled “Dear Health Care Provider Letters: Improving Communication of Important Safety Information.” DHCP letters are correspondence from a manufacturer or distributor to health care providers containing new or updated information regarding a human drug or biologic. These letters have become more commonly delivered electronically via email and online postings rather than a physical post. The guidance provides recommendations on--